ALDH1A1 and metastatic malignant neoplasm in the lymph nodes: However, our analysis did not reveal any significant association between the expression levels of TSP50/p-AKT/ALDH1 and clinical parameters such as patient age or the presence of axillary lymph node metastases (Fig. 12H and I).